InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
2
T+90 hit rate
53%
T+90 mean return
-4.1%
Across 17 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Hippel James, Chief Financial Officer. Director active across 1 company, notably BIO-TECHNE Corp. Aggregated, 22 reports have been published. Breakdown: 0 buy · 2 sells. Total volume traded: €90k. Activity tracked since 7 June 2021. The latest transaction was filed on 1 November 2024 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations22 total
13,159 shares0Common StockSEC:0001062993-24-018333:0
6,475 shares@ US$75.312.9% of flowCommon StockSEC:0001062993-24-018333:1
53,000 shares@ US$31.269.8% of flowCommon StockSEC:0001062993-24-014510:0
36,076 shares@ US$82.3517.6% of flowCommon StockSEC:0001062993-24-014510:1
35,000 shares@ US$31.266.4% of flowCommon StockSEC:0001062993-24-014086:0
47,289 shares@ US$31.268.7% of flowCommon StockSEC:0001062993-23-023028:0
12,876 shares0Common StockSEC:0001062993-23-016038:0
6,335 shares@ US$82.173.0% of flowCommon StockSEC:0001062993-23-016038:1
1,938 shares@ US$382.974.7% of flowCommon StockSEC:0001437749-22-019662:1
3,938 shares0Common StockSEC:0001437749-22-019662:0
8,822 shares@ US$125.050.014% mcap13.0% of flowCommon StockSEC:0000914190-21-000403:0
8,822 shares@ US$125.056.1% of flowCommon StockSEC:0000914190-21-000403
100 shares@ US$525.180.0007% mcap0.6% of flowCommon StockSEC:0000914190-21-000394:0
100 shares@ US$525.180.3% of flowCommon StockSEC:0000914190-21-000394
10,000 shares@ US$106.590.013% mcap12.2% of flowCommon StockSEC:0000914190-21-000359:0
10,000 shares@ US$106.595.7% of flowCommon StockSEC:0000914190-21-000359
3,383 shares0Common StockSEC:0000914190-21-000216:0
3,383 shares0Common StockSEC:0000914190-21-000216
10,000 shares@ US$106.590.013% mcap12.3% of flowCommon StockSEC:0000914190-21-000195:0
10,000 shares@ US$106.595.7% of flowCommon StockSEC:0000914190-21-000195
9,942 shares@ US$106.590.013% mcap11.9% of flowCommon StockSEC:0000914190-21-000181:0
9,942 shares@ US$106.595.6% of flowCommon StockSEC:0000914190-21-000181
22 of 22 declarations
About Hippel James
James Hippel is Chief Financial Officer at BIO-TECHNE Corp. He is responsible for financial management and financial strategy for the company. His role is essential in ensuring financial health and compliance in operations.
